The Fas receptor - 1,4,5-IP₃ cascade: A potential target for treating heart failure and arrhythmias

Keyphrases

• Heart Failure 100%
• Myocytes 100%
• Heart Arrhythmia 100%
• Fas Receptor 100%
• Receptor 1 100%
• Normoxic 83%
• Ventricular Myocytes 66%
• Ca2+ 33%
• Anti-apoptotic Proteins 33%
• Non-apoptotic Functions 33%
• Fas-mediated Apoptosis 33%
• Arrhythmia 33%
• Apoptosis 16%
• Functional Consequences 16%
• Hypoxia 16%
• Insults 16%
• Tyrosine Kinase 16%
• Resting Potential 16%
• Myocarditis 16%
• Myocardium 16%
• Tyrosine Phosphorylation 16%
• Genistein 16%
• Action Potential Amplitude 16%
• Phospholipase C 16%
• Action Potential Duration 16%
• Functional Disturbances 16%
• Prolonged Action 16%
• Early Afterdepolarization 16%
• Fas Ligand Protein 16%
• Mechanical Dysfunction 16%
• Delayed Afterdepolarization 16%
• Myocardial Pathology 16%
• Ischemia-reperfusion 16%
• Fas-FasL Pathway 16%

Biochemistry, Genetics and Molecular Biology

• Fas Receptor 100%
• Cardiac Dysrhythmia 100%
• Programmed Cell Death 100%
• Tyrosine 33%
• Tyrosine Phosphorylation 33%
• Membrane Steady Potential 33%
• Afterdepolarization 33%
• Reperfusion 33%
• Action Potential Amplitude 33%
• Action Potential Duration 33%
• Lecithinase 33%
• Genistein 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Heart Arrhythmia 100%
• Tumor Necrosis Factor Receptor Superfamily Member 6 100%
• Calcium Ion 33%
• Pathophysiology 33%
• Antiapoptotic 33%
• Protein Tyrosine Kinase 33%
• Myocarditis 33%
• Hypoxia 33%
• Genistein 33%
• Tyrosine 33%
• Lecithinase 33%